Few people actually benefit from ‘breakthrough’ cancer immunotherapy

8 March 2017 - People with cancer face many challenges, including the symptoms of the disease, the toxicity of the ...

Read more →

Health groups denounce G.O.P. bill as its backers scramble

8 March 2017 - Influential groups representing hospitals and nurses came out on Wednesday against a Republican bill to repeal ...

Read more →

American Medical Association opposes Republican health plan

8 March 2017 - The American Medical Association, a powerful lobbying group representing the nation’s doctors, announced on Wednesday that ...

Read more →

Amending Obamacare could break parts of the health insurance market

10 March 2017 - It is far from clear that the Republican plan will work. ...

Read more →

Trump meets with Democrats at White House on drug prices

9 March 2017 - Democrats presented Trump with plan for Medicare negotiations. ...

Read more →

Despite discounts for hepatitis C drugs, coverage denials continue to rise

8 March 2017 - After pricey new hepatitis C treatments emerged a few years ago, public and private payers restricted ...

Read more →

PolyPid announces receipt of qualified infectious disease product designation from FDA for D-Plex in post-cardiac surgery sternal infection

8 March 2017 - Company intends to seek regulatory approvals in U.S. and Europe in coming year to conduct Phase ...

Read more →

PTC Therapeutics announces FDA acknowledgment of new drug application filing for Translarna for the treatment of nonsense mutation Duchenne muscular dystrophy

6 March 2017 - FDA has assigned a PDUFA date of 24 October 2017. ...

Read more →

No wonder the republicans hid the health bill

7 March 2017 - Republican House leaders have spent months dodging questions about how they would replace the Affordable Care ...

Read more →

Insurers, drug companies testify against drug pricing bill

7 March 2017 - Health insurers, the state's Insurance Department and pharmaceutical companies with major operations in Connecticut testified against ...

Read more →

FDA accepts supplemental new drug application for Vraylar (cariprazine)

8 March 2017 - Application seeks to expand Vraylar label to include phase 3 clinical data for the maintenance treatment ...

Read more →

Lower $1,000 pill price? We'd love it, says Express Scripts

8 March 2017 - Pharmacy manager sends letter to Gilead asking for price cut. ...

Read more →

High U.S. drug prices cannot be explained by R&D spending alone

7 March 2017 - Pharmaceutical companies often cite research and development spending to justify high drug prices in the U.S. ...

Read more →

G.O.P. health bill faces revolt from conservative forces

7 March 2017 - After seven years of waiting longingly to annul President Barack Obama’s signature health care law, Republican ...

Read more →

FDA grants fast track designation for Mesoblast's cell therapy in children with acute graft versus host disease

7 March 2017 - Mesoblast today announced that the US FDA has granted a fast track designation for the use of ...

Read more →